TRINETRA › Sectors › Chemicals

Fineotex Chemical Limited (FCL) — share price, P/E and fundamentals

Fineotex Chemical Limited (NSE: FCL) closed at ₹48.39 on 30 Oct 2026, +97.8% over one year, against a 52-week range of ₹19.10 – ₹62.40.

In the quarter ended 30 Jun 2026 (consolidated, filed 23 Jul 2026) it reported revenue of ₹377 cr and net profit of ₹38 cr, a 10.2% net margin; revenue grew 174.8% and profit grew 105.6% year on year.

From the balance sheet dated 31 Mar 2026: return on equity 17.4%, ROCE 27.2%, debt-to-equity 0.01, Piotroski F-score 2 of 9.

Against 43 Chemicals peers on NSE: Net margin higher than 51% of 43 sector peers; PBT margin higher than 58% of 43 sector peers; ROE higher than 73% of 41 sector peers.

Key figures

Last close₹48.39 (30 Oct 2026)
Change 1 month / 6 months / 1 year-13.7% / +111.2% / +97.8%
52-week low – high₹19.10 – ₹62.40
Quarter revenue₹377 cr
Quarter net profit₹38 cr
Net margin10.2%
Revenue growth (YoY)+174.8%
Profit growth (YoY)+105.6%
Return on equity17.4%
ROCE27.2%
Debt / equity0.01
Current ratio2.77
Free cash flow₹-48 cr
Piotroski F-score2 / 9
Average daily turnover (50 days)₹96.2 cr

Against Chemicals peers

MetricFCLPeer medianPercentile
Net margin10.209.9151
PBT margin17.1913.2958
ROE17.4113.6473
ROCE27.1916.0885
Debt / equity0.010.2324
Cash conversion-0.190.9518

Questions

What were Fineotex Chemical Limited's latest quarterly results?

For the quarter ended 30 Jun 2026, Fineotex Chemical Limited reported revenue of ₹377 cr and net profit of ₹38 cr (consolidated), filed with the exchange on 23 Jul 2026.

What is Fineotex Chemical Limited's ROE?

Return on equity is 17.4% based on the balance sheet dated 31 Mar 2026.

Does Fineotex Chemical Limited have debt?

Debt-to-equity is 0.01 on the balance sheet dated 31 Mar 2026.

What is FCL's 52-week high and low?

Over the last 52 weeks to 30 Oct 2026, FCL traded between ₹19.10 and ₹62.40.

Other Chemicals stocks

Source: consolidated SEBI Integrated Filing for the quarter ended 30 Jun 2026 and NSE daily closes. Open the interactive terminal view for charts and the full statements.

TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing. Figures are as filed with NSE/SEBI and as of the dates shown; they are not live prices.